Your search returned 7 results.

Results
	1.	Effect of canagliflozin, a sodium-glucose cotransporter 2 inhibitor, on measurement of serum 1,5-anhydroglucitol. [electronic resource] by Balis, Dainius A Tong, Cindy Meininger, Gary Producer: 20150122 In: Journal of diabetes vol. 6 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Canagliflozin improves risk factors of metabolic syndrome in patients with type 2 diabetes mellitus and metabolic syndrome. [electronic resource] by Davies, Michael J Merton, Katherine W Vijapurkar, Ujjwala Balis, Dainius A Desai, Mehul Publication details: Diabetes, metabolic syndrome and obesity : targets and therapy 2017 In: Diabetes, metabolic syndrome and obesity : targets and therapy vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Assessment of musculoskeletal toxicity 5 years after therapy with levofloxacin. [electronic resource] by Bradley, John S Kauffman, Ralph E Balis, Dainius A Duffy, Ciaran M Gerbino, Peter G Maldonado, Samuel D Noel, Gary J Producer: 20140904 In: Pediatrics vol. 134 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial. [electronic resource] by Cefalu, William T Leiter, Lawrence A Yoon, Kun-Ho Arias, Pablo Niskanen, Leo Xie, John Balis, Dainius A Canovatchel, William Meininger, Gary Producer: 20130926 In: Lancet (London, England) vol. 382 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Canagliflozin provides durable glycemic improvements and body weight reduction over 104 weeks versus glimepiride in patients with type 2 diabetes on metformin: a randomized, double-blind, phase 3 study. [electronic resource] by Leiter, Lawrence A Yoon, Kun-Ho Arias, Pablo Langslet, Gisle Xie, John Balis, Dainius A Millington, Dawn Vercruysse, Frank Canovatchel, William Meininger, Gary Producer: 20150827 In: Diabetes care vol. 38 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	A randomized comparative study of levofloxacin versus amoxicillin/clavulanate for treatment of infants and young children with recurrent or persistent acute otitis media. [electronic resource] by Noel, Gary J Blumer, Jeffrey L Pichichero, Michael E Hedrick, James A Schwartz, Richard H Balis, Dainius A Melkote, Rama Bagchi, Partha Arguedas, Adriano Producer: 20080703 In: The Pediatric infectious disease journal vol. 27 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Comparative safety profile of levofloxacin in 2523 children with a focus on four specific musculoskeletal disorders. [electronic resource] by Noel, Gary J Bradley, John S Kauffman, Ralph E Duffy, Ciaran M Gerbino, Peter G Arguedas, Adriano Bagchi, Partha Balis, Dainius A Blumer, Jeffrey L Producer: 20071127 In: The Pediatric infectious disease journal vol. 26 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)